PRA Health Sciences, Inc. Reports Third Quarter 2020 Results and Updates Full Year 2020 GuidanceGlobeNewsWire • 11/04/20
Analysts Estimate PRA Health Sciences (PRAH) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 10/28/20
PRA Health Sciences selected by BARDA to be a member of its exclusive Clinical Studies NetworkGlobeNewsWire • 10/06/20
PRA Health Sciences: A Solid Investment Case But Watch Out For Signs Of InertiaSeeking Alpha • 09/21/20
PRA Health Sciences and Deep Lens announce strategic relationship to accelerate patient recruitment for precision cancer trialsGlobeNewsWire • 09/18/20
Why Is PRA Health Sciences (PRAH) Down 9.1% Since Last Earnings Report?Zacks Investment Research • 09/05/20
PRA Health Sciences Joins The Leukemia & Lymphoma Society on Global Trial for Children with Acute LeukemiaPRNewsWire • 09/03/20
PRA Health Sciences, Inc. (PRAH) CEO Colin Shannon on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/07/20
PRA Health Sciences, Inc. Reports Second Quarter 2020 Results and Provides Third Quarter and Full Year 2020 GuidanceGlobeNewsWire • 08/06/20
Stock Upgrades: PRA Health Sciences Shows Rising Relative StrengthInvestors Business Daily • 07/28/20
PRA Health Sciences ready to navigate RACE Act requirements for pediatric oncologyGlobeNewsWire • 06/18/20
PRA Enhances COVID-19 Monitoring Program with Integration of Microsoft Healthcare Bot ServiceGlobeNewsWire • 06/12/20
Why Is PRA Health Sciences (PRAH) Up 7.3% Since Last Earnings Report?Zacks Investment Research • 05/30/20
PRA Health Sciences, Inc. (PRAH) CEO Colin Shannon on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/01/20
PRA Health Sciences (PRAH) Surpasses Q1 Earnings and Revenue EstimatesZacks Investment Research • 04/30/20
Will PRA Health Sciences (PRAH) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 04/29/20